| Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy (NCT05414162) | University Hospital, Bonn | 2022-05-16 |
| Venetoclax Plus Inotuzumab for B-ALL (NCT05016947) | Dana-Farber Cancer Institute | 2021-09-24 |
| Optical Genome Mapping in Hematological Malignancies (NCT05009537) | University Hospital, Brest | 2021-09-01 |
| ACL Reconstruction With/Without ALL Reconstruction (NCT05461625) | Centre of Postgraduate Medical Education | 2021-09-01 |
| Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders (NCT04644016) | Memorial Sloan Kettering Cancer Center | 2020-11-20 |
| GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL (NCT04601584) | AO GENERIUM | 2020-10-15 |
| Haplo Peripheral Blood Sct In GVHD Prevention (NCT04473911) | Zachariah Michael DeFilipp | 2020-08-14 |
| Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Isolated ACL Reconstruction and a Reconstruction Combining ACL and ALL (NCT05123456) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2020-04-15 |
| Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia (NCT03571321) | University of Chicago | 2019-05-28 |
| A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant (NCT03739502) | University of Rochester | 2019-02-28 |
| Haploidentical Donor vs mMUD in Hematological Malignancies (NCT03275636) | DKMS gemeinnützige GmbH | 2018-01-01 |
| Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders (NCT03198234) | Roncarolo, Maria Grazia, MD | 2017-08-30 |
| Family History in a Singaporean Healthy Population (NCT03114553) | Duke University | 2017-07-23 |
| Project Baseline Health Study (NCT03154346) | Baseline Study LLC | 2017-03-29 |
| Amish/Mennonite Research Contact Registry (NCT02990572) | University of Pittsburgh | 2016-10-01 |
| Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia (NCT02795520) | OncoTherapy Science, Inc. | 2016-04-01 |
| Collaborative Network to Take Responsibility for Oral Anticancer Therapy (NCT02861209) | KU Leuven | 2015-11-01 |
| Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies (NCT02315612) | National Cancer Institute (NCI) | 2014-12-12 |
| Photochemotherapy and Graft-versus-leukemia in Acute-leukemia (NCT02631993) | Karolinska University Hospital | 2014-10-01 |
| Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL (NCT02133599) | Ann & Robert H Lurie Children's Hospital of Chicago | 2014-07-24 |
| Massage Therapy Versus Music Therapy Pilot Study (NCT02227680) | Boston Medical Center | 2014-07-01 |
| Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia (NCT02528435) | University of Aarhus | 2013-12-01 |
| Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma (NCT01593696) | National Cancer Institute (NCI) | 2012-06-29 |
| A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives (NCT01532635) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-03-01 |
| POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients (NCT01319864) | Seattle Children's Hospital | 2011-03-01 |
| Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia (NCT01230788) | Emory University | 2010-09-01 |
| Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies (NCT01204164) | Tragara Pharmaceuticals, Inc. | 2010-08-01 |
| Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT (NCT01012492) | Boston Children's Hospital | 2009-11-01 |
| Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) (NCT00863148) | Nantes University Hospital | 2009-10-01 |
| A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia (NCT00964873) | Synta Pharmaceuticals Corp. | 2009-08-01 |
| Umbilical Cord Blood Transplant for Hematological Malignancies (NCT00891592) | University of Pennsylvania | 2009-01-01 |
| Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) (NCT00815568) | Samsung Medical Center | 2008-08-01 |
| Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft (NCT00814983) | Duke University | 2007-07-01 |
| Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD (NCT00539695) | Baylor College of Medicine | 2007-06-01 |
| Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies (NCT00776373) | Abramson Cancer Center at Penn Medicine | 2007-01-01 |
| Testing the Re-Engineered Hospital Discharge (NCT00252057) | Boston University | 2005-12-01 |
| CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation (NCT00333190) | Dana-Farber Cancer Institute | 2005-09-01 |
| Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders (NCT00533923) | Beth Israel Deaconess Medical Center | 2002-12-01 |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies (NCT00013533) | National Cancer Institute (NCI) | 2001-03-14 |
| Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders (NCT00636909) | Beth Israel Deaconess Medical Center | 1999-07-01 |
| Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders (NCT00511537) | University of California, San Francisco | 1999-01-01 |